Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04383990
Other study ID # RJ19/175/J
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 28, 2020
Est. completion date November 30, 2020

Study information

Verified date May 2020
Source King Abdullah International Medical Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare different timing of insulin Glargine administration (early-6 pm versus standard bedtime-10 pm) as part of standard of care in patients with type1 diabetes who wish to fast the month of Ramadan.


Description:

The investigators aim to compare the effectiveness and safety of two management strategies currently used in basal insulin adjustment for treatment of Type1 diabetes (T1DM) during fasting the holy month of Ramadan. Primary Objective: To determine if taking basal insulin Glargine at 6 pm is associated with less rates of hypoglycemia -(we will consider glucose level of 70 mg/dl ( 3.9 mmol/l) and below as the level of hypoglycemia ) - compared to bedtime timing (10-12pm) during fasting Ramadan in patients with T1DM Secondary Objectives: 1. To estimate the difference between the two groups in glucose variability 2. To estimate the difference between the two groups in number of days they needed to brake their fast 3. To assess the difference in glycemic control between the two groups 4. To estimate the difference between the two groups in overnight and daytime hyperglycemia. 5. To estimate the difference between the two groups in rate of severe hyperglycemia and /or DKA It is a multi-center open label randomized study that will take place in the diabetes/Endocrine clinics at National Guards Hospitals in four cities (Jeddah, Riyadh, Alhasa, and Dammam) Variables to be Assessed: 1. Patient's demographics including (age, gender, type and duration of diabetes), and baseline measurements (weight, height,BMI, …). 2. Rate of Hypoglycemic events (as per SMBG records and CGM) in both groups 3. Number of days fasting was broken in both groups 4. Rate of severe hyperglycemic episodes (BG>250mg/dl) or DKA in both groups 5. Mean blood glucose for the month of Ramadan as calculated from sum of each patient's 7-point blood sugar home measurements in both groups. 6. Mean 24-hour blood glucose as measured by a continuous glucose monitoring devise in both groups. 7. Mean fasting blood glucose for the month period as calculated from patients home blood sugar measurements in both groups. 8. Mean 2-hour post-prandial blood glucose for the as calculated from patients home blood sugar measurements in both groups. 9. Fructosamine and HbA1c level before and after Ramadan in both groups Results of this study will help fill a current gap of knowledge and may also contribute to the development of future guidelines for the management of type1DM during Ramadan.


Recruitment information / eligibility

Status Completed
Enrollment 185
Est. completion date November 30, 2020
Est. primary completion date August 31, 2020
Accepts healthy volunteers No
Gender All
Age group 14 Years and older
Eligibility Inclusion Criteria: 1. DM type 1 2. Age > 14 years 3. Diagnosis of type 1 DM of more than 6 months. 4. Committed to do SMBG Exclusion Criteria: 1. Renal and hepatic impairment 2. Adrenal insufficiency 3. Pregnancy 4. Alcohol consumption 5. Any diagnosed psychiatric disease

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Timing of taking insulin
To take insulin Glargine early (6-7pm) or late (bedtime-10-12pm)

Locations

Country Name City State
Saudi Arabia KingAbullahIMRC Jeddah

Sponsors (1)

Lead Sponsor Collaborator
King Abdullah International Medical Research Center

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hypoglycemia incidence To determine if taking basal insulin Glargine at 6 pm is associated with less rates of hypoglycemia -(we will consider glucose level of 70 mg/dl ( 3.9 mmol/l) and below as the level of hypoglycemia ) - compared to bedtime timing (10-12pm) during fasting Ramadan in patients with T1DM. Through study completion, an average of 3 months
Secondary Glucose variability To estimate the difference between the two groups in glucose variability as measured by standard deviation on glucose monitoring Through study completion, an average of 3 months
Secondary Days fast broken To estimate the difference between the two groups in number of days they needed to brake their fast Through study completion, an average of 3 months
Secondary Glycemic control To assess the difference in glycemic control between the two groups as measured by hbA1c and frucosamine before and after Ramadan Through study completion, an average of 3 months
Secondary Hyperglycemia To estimate the difference between the two groups in overnight and daytime rates of hyperglycemia (BG > 250 mg/dl) Through study completion, an average of 3 months
Secondary Acute diabetes complications To estimate the difference between the two groups in rate of severe hyperglycemia (hypoglycemia associated with need for outside assisstance) and /or presentation to ER with Diabetic Keto-acidosis (DKA) Through study completion, an average of 3 months
See also
  Status Clinical Trial Phase
Completed NCT03886974 - Transition to Adult Care in Type 1 Diabetes
Completed NCT05620251 - Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes
Completed NCT03623113 - The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 Diabetes N/A
Active, not recruiting NCT05078658 - Low-carbohydrate Diet in Children With Type 1 Diabetes N/A
Not yet recruiting NCT06018324 - CloudCare in the Treatment of Type 1 Diabetes in Pediatrics
Withdrawn NCT03736083 - Introducing CGM at Type 1 Diabetes Diagnosis N/A
Completed NCT03177096 - Impact of the Continuous Measurement of Blood Glucose on Insulin Pump on Child Quality of Life With Type 1 Diabetes N/A
Not yet recruiting NCT06418269 - The Effect of Therapeutic Play on Anxiety and Fear Levels in Children With Diabetes N/A
Completed NCT04172077 - Self Efficacy Levels, Attachment Style and Resiliency of Youth With Type 1 Diabetes
Recruiting NCT04950634 - Sexual Dimorphism in Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes
Completed NCT04450745 - Physical Exercise in Normobaric Hypoxia and Normoxia in Type 1 Diabetic Patients N/A
Completed NCT03165786 - A Cognitive Behavioral Intervention to Reduce Fear of Hypoglycemia in Young Adults With Type 1 Diabetes N/A
Terminated NCT04028960 - IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase Phase 2
Recruiting NCT05324488 - Diabetes Registry Graz for Biomarker Research
Completed NCT02984709 - Check It! 2.0: Positive Psychology Intervention for Adolescents With Type 1 Diabetes N/A
Completed NCT02984514 - Brown Adipose Tissue in Type 1 Diabetes N/A
Recruiting NCT06372392 - Universal Fixed Meal Boluses Usage in Patients With Medtronic Minimed 780G Pumps N/A
Recruiting NCT03311516 - New Insulin Therapy by Multiwave Bolus N/A
Recruiting NCT05973799 - Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes N/A
Completed NCT03711656 - Prediction and Prevention of Nocturnal Hypoglycemia in Persons With Type 1 Diabetes Using Machine Learning Techniques N/A